Achieve Life Sciences, Inc.

ACHV

Exchange: Nasdaq
Industry: In Vitro & In Vivo Diagnostic Substances
SEC CIK: 0000949858

SEC filings (opens in a new tab)

In the last 90 days, Achieve Life Sciences, Inc. insiders filed 0 open-market purchases and 1 sale; 111 institutions reported holding it in 13F filings for Q2 2026, worth $538.7M in total; no superinvestor holds it.

Superinvestors holding ACHV, Q2 2026

See all superinvestors

No superinvestor reported holding ACHV in Q2 2026.